Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06456060Phase 1Recruiting
Phase 1, open-label trial of Revamil in alveolar osteitis (AO) (2 arms), sponsored by Watim Medical and Dental College. Primary endpoints: Pain relief on Visual Analog Scale at 7 days and Success rate of the procedure at 2 weeks. Started Jun 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06456060.